JAGX
Price
$2.71
Change
-$0.21 (-7.19%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
3.43M
SNPX
Price
$4.89
Change
+$1.12 (+29.71%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
6.81M
Interact to see
Advertisement

JAGX vs SNPX

Header iconJAGX vs SNPX Comparison
Open Charts JAGX vs SNPXBanner chart's image
Jaguar Health
Price$2.71
Change-$0.21 (-7.19%)
Volume$525
Capitalization3.43M
Synaptogenix
Price$4.89
Change+$1.12 (+29.71%)
Volume$2.16K
Capitalization6.81M
JAGX vs SNPX Comparison Chart in %
Loading...
JAGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JAGX vs. SNPX commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JAGX is a Buy and SNPX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (JAGX: $2.71 vs. SNPX: $4.90)
Brand notoriety: JAGX and SNPX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: JAGX: 78% vs. SNPX: 58%
Market capitalization -- JAGX: $3.43M vs. SNPX: $6.81M
JAGX [@Biotechnology] is valued at $3.43M. SNPX’s [@Biotechnology] market capitalization is $6.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JAGX’s FA Score shows that 1 FA rating(s) are green whileSNPX’s FA Score has 2 green FA rating(s).

  • JAGX’s FA Score: 1 green, 4 red.
  • SNPX’s FA Score: 2 green, 3 red.
According to our system of comparison, SNPX is a better buy in the long-term than JAGX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JAGX’s TA Score shows that 4 TA indicator(s) are bullish.

  • JAGX’s TA Score: 4 bullish, 3 bearish.

Price Growth

JAGX (@Biotechnology) experienced а -2.52% price change this week, while SNPX (@Biotechnology) price change was +19.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.59%. For the same industry, the average monthly price growth was +34.25%, and the average quarterly price growth was +14.95%.

Reported Earning Dates

JAGX is expected to report earnings on Mar 31, 2025.

SNPX is expected to report earnings on Mar 27, 2025.

Industries' Descriptions

@Biotechnology (+3.59% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNPX($6.81M) has a higher market cap than JAGX($3.43M). SNPX has higher P/E ratio than JAGX: SNPX (2.75) vs JAGX (0.01). SNPX YTD gains are higher at: 41.210 vs. JAGX (-89.267). SNPX has higher annual earnings (EBITDA): -6.18M vs. JAGX (-37.39M). SNPX has more cash in the bank: 14.8M vs. JAGX (5.69M). JAGX has higher revenues than SNPX: JAGX (11.6M) vs SNPX (0).
JAGXSNPXJAGX / SNPX
Capitalization3.43M6.81M50%
EBITDA-37.39M-6.18M605%
Gain YTD-89.26741.210-217%
P/E Ratio0.012.750%
Revenue11.6M0-
Total Cash5.69M14.8M38%
Total Debt38.3MN/A-
FUNDAMENTALS RATINGS
JAGX: Fundamental Ratings
JAGX
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
29
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
JAGX
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
N/A
Momentum
ODDS (%)
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 29 days ago
83%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
JAGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DREYX41.200.13
+0.32%
Davis Real Estate Y
MSIQX11.60N/A
N/A
Morgan Stanley Inst International Eq I
OPOCX97.14N/A
N/A
Invesco Discovery A
MGKQX14.32N/A
N/A
Morgan Stanley Global Permanence R6
WFINX55.41N/A
N/A
Allspring Index C

JAGX and

Correlation & Price change

A.I.dvisor tells us that JAGX and RNAZ have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that JAGX and RNAZ's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JAGX
1D Price
Change %
JAGX100%
-7.19%
RNAZ - JAGX
31%
Poorly correlated
+7.18%
DVHGF - JAGX
27%
Poorly correlated
N/A
SNPX - JAGX
26%
Poorly correlated
+29.97%
SLNO - JAGX
26%
Poorly correlated
-2.06%
ACET - JAGX
26%
Poorly correlated
+1.91%
More

SNPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNPX has been closely correlated with NCNA. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if SNPX jumps, then NCNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNPX
1D Price
Change %
SNPX100%
+29.97%
NCNA - SNPX
92%
Closely correlated
-6.67%
RNAC - SNPX
91%
Closely correlated
+6.51%
AGEN - SNPX
91%
Closely correlated
-0.41%
ALLR - SNPX
87%
Closely correlated
-1.10%
NRXP - SNPX
84%
Closely correlated
+7.03%
More